Subscribe To
Xilio Therapeutics to Host Live Virtual Program Spotlighting XTX301, a Tumor-Activated IL-12
WALTHAM, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that the company will host a live virtual program on Thursday, December 1, 2022, at 12:30 p.m. ET spotlighting Xilio’s clinical-stage molecule XTX301, a tumor-activated, engineered IL-12. The […] The post Xilio Therapeutics to Host Live Virtual Program Spotlighting XTX301, a Tumor-Activ...
Read More
Content Topics
Xilio
Therapeutics
Host
Live
Virtual
Program
Spotlighting
Xtx301
Tumor activated
Forex
Posted: Nov 23 2022, 12:30
Author Name: forextv
Views: 102499